Basically, this was Stoney's last post aside from a few that followed pre-market that day. It was regarding MRTX. Stoney!!! Fear not and look at the bright side.. at least you have VZ who will of course tell you what stocks to buy and when... so you can make it all back. A little seasoning is good for the ego ain't it Stoney?
Good morning Everyone. Papa is fine. Don't worry. MRTX was a bloody disaster. I had all of 70 shares. It's my smallest position. What gets me really mad is I was going to remove it and actually was about to do so and I found a couple grand lying around and rather than walk away I folded it in buying 20 more shares... I don't like acting like that.
I am happy to say ZERO children are in the MRTX fiasco, I asked around. Seven of the Children have Trane in their IRA though... Trane price target raised to $204 from $185 at Citi
Quanta Services price target raised to $175 from $161 at Citi GMS Inc. price target raised to $67 from $56 at Baird Fortive price target raised to $77 from $73 at Citi
Gain Therapeutics initiated with a Buy at Chardan 07:06 GANX Karuna Therapeutics assumed with a Buy at Mizuho
We sold SHOP slightly higher than where it is now-- Shopify price target raised to $45 from $40 at SMBC Nikko 06:22 SHOP SMBC Nikko analyst Andrew Bauch raised the firm's price target on Shopify to $45 from $40 and keeps an Outperform rating on the shares. The analyst says Shopify is one of the few names in his coverage with the potential to accelerate sales growth and expand margins simultaneously in 2023. He sees "see several emerging and SHOP-specific opportunities, the most important being the evolution of Shopify's Payment strategy." Bauch recommends investors accumulate the shares opportunistically.
Remember we have this Fri and next Fri picked out for acceleration days. The Lizard King has reloaded yesterday and is back in on the long side. Lizard King's record is 6-1 (we're calling the last one a victory but it was not our usual 100 + points.)
We have a very large Carrier position (six accounts) // still waiting for the break out. Carrier Global price target raised to $45 from $39 at Citi 06:58 CARR Citi analy
Chewy price target raised to $35 from $30 at Barclays 06:18 CHWY Barclays analyst Trevor Young raised the firm's price target on Chewy to $35 from $30 and keeps an Equal Weight rating on the shares post the Q3 results. The company reported a beat across all all key line items as active customer growth turned slightly positive quarter-over-quarter and NSPAC continued healthy gains, Young tells investors in a research note.
GUMMY OF THE DAY - EVO @ $8.50 <---------- Evotec SE (EVO) NasdaqGS - NasdaqGS Real Time Price. 8.38+0.07 (+0.84%) At close: December 8 04:00PM EST 8.51 +0.13 (+1.55%)<----------------- If you play pre market GET IN. Pre-Market: 07:00AM EST